Bilateral brain reorganization with memantine and constraint-induced aphasia therapy in chronic post-stroke aphasia: An ERP study

Brain Lang. 2015 Jun-Jul:145-146:1-10. doi: 10.1016/j.bandl.2015.04.003. Epub 2015 Apr 29.

Abstract

Changes in ERP (P100 and N400) and root mean square (RMS) were obtained during a silent reading task in 28 patients with chronic post-stroke aphasia in a randomized, double-blind, placebo-controlled trial of both memantine and constraint-induced aphasia therapy (CIAT). Participants received memantine/placebo alone (weeks 0-16), followed by drug treatment combined with CIAT (weeks 16-18), and then memantine/placebo alone (weeks 18-20). ERP/RMS values (week 16) decreased more in the memantine group than in the placebo group. During CIAT application (weeks 16-18), improvements in aphasia severity and ERP/RMS values were amplified by memantine and changes remained stable thereafter (weeks 18-20). Changes in ERP/RMS occurred in left and right hemispheres and correlated with gains in language performance. No changes in ERP/RMS were found in a healthy group in two separated evaluations. Our results show that aphasia recovery induced by both memantine alone and in combination with CIAT is indexed by bilateral cortical potentials.

Keywords: Aphasia recovery; Constraint-induced aphasia therapy; Event-related potentials; Memantine; Stroke.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aphasia / etiology
  • Aphasia / physiopathology
  • Aphasia / therapy*
  • Brain / drug effects
  • Brain / physiology*
  • Double-Blind Method
  • Evoked Potentials / drug effects
  • Evoked Potentials / physiology*
  • Female
  • Functional Laterality / drug effects
  • Functional Laterality / physiology
  • Humans
  • Language Therapy / methods*
  • Male
  • Memantine / pharmacology
  • Memantine / therapeutic use*
  • Middle Aged
  • Photic Stimulation / methods
  • Reading
  • Stroke / complications
  • Stroke / physiopathology
  • Stroke / therapy*

Substances

  • Memantine